These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 6754184)

  • 1. The renin-angiotensin system and hypertension.
    Williams GH
    Clin Exp Pharmacol Physiol Suppl; 1982; 7():31-40. PubMed ID: 6754184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium sensitive hypertension: renal and adrenal non-modulation in its pathogenesis.
    Hollenberg NK; Williams GH
    Kidney; 1988 Nov; 21(3):13-8. PubMed ID: 11538850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute inhibition of the renin-angiotensin system: interest and limits to detect surgically curable hypertension.
    Pagny JY; Thibonnier M; Corvol P; Menard J
    J Cardiovasc Pharmacol; 1985; 7 Suppl 4():S82-5. PubMed ID: 2412019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Volume control and altered renal and adrenal responsiveness to angiotensin in essential hypertension: implications for treatment with converting enzyme inhibition.
    Hollenberg NK; Williams GH
    J Hypertens Suppl; 1983 Oct; 1(1):119-28. PubMed ID: 6100600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The state and responsiveness of the renin-angiotensin-aldosterone system in patients with type II diabetes mellitus.
    Price DA; De'Oliveira JM; Fisher ND; Williams GH; Hollenberg NK
    Am J Hypertens; 1999 Apr; 12(4 Pt 1):348-55. PubMed ID: 10232494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II type 1 receptor messenger RNA levels in human blood cells of patients with primary and secondary hypertension: reference to renin profile.
    Shibata H; Suzuki H; Murakami M; Sato A; Saruta T
    J Hypertens; 1994 Nov; 12(11):1275-84. PubMed ID: 7868875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysregulation of aldosterone secretion and its relationship to the pathogenesis of essential hypertension.
    Williams GH; Moore TJ; Hollenberg NK
    Endocrinol Metab Clin North Am; 1991 Jun; 20(2):423-47. PubMed ID: 1879402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal abnormalities in nonmodulating essential hypertension.
    Williams GH; Moore TJ; Hollenberg NK
    Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):39-44. PubMed ID: 3037888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between blood pressure and renin, angiotensin II and atrial natriuretic factor after renal transplantation.
    Hestin D; Mertes PM; Hubert J; Claudon M; Mejat E; Renoult E; Pertek JP; Frimat L; Burlet C; Kessler M
    Clin Nephrol; 1997 Aug; 48(2):98-103. PubMed ID: 9285146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The renin system and new understanding of the complications of hypertension and their treatment.
    Laragh JH
    Arzneimittelforschung; 1993 Feb; 43(2A):247-54. PubMed ID: 8498972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of renin angiotensin system in the vasopressor mechanisms of hypertension--gene analyses and tissue renin angiotensin system].
    Nishimura M; Yoshimura M
    Rinsho Byori; 1995 Nov; 43(11):1128-32. PubMed ID: 8551676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between serum cholesterol levels and the renin-angiotensin system on the new onset of arterial hypertension in subjects with high-normal blood pressure.
    Borghi C; Veronesi M; Cosentino E; Cicero AF; Kuria F; Dormi A; Ambrosioni E
    J Hypertens; 2007 Oct; 25(10):2051-7. PubMed ID: 17885547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal mechanisms of angiotensin II-induced hypertension.
    Granger JP; Schnackenberg CG
    Semin Nephrol; 2000 Sep; 20(5):417-25. PubMed ID: 11022893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New data on hormone-dependent hypertension and their significance for the practice].
    Horký K; Petrásek J; Marek J
    Cas Lek Cesk; 1973 Jan; 112(1):3-11. PubMed ID: 4345613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathogenesis of renal hypertension].
    Cottier P
    Schweiz Med Wochenschr; 1975 Dec; 105(50):1670-7. PubMed ID: 1215954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertension following renal transplantation: the role of the host's kidney.
    McHugh MI; Tanboga H; Marcen R; Liano F; Robson V; Wilkinson R
    Q J Med; 1980; 49(196):395-403. PubMed ID: 7022539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered regulation of renal interstitial hydrostatic pressure and the renal renin-angiotensin system in the absence of atrial natriuretic peptide.
    O'Tierney PF; Komolova M; Tse MY; Adams MA; Pang SC
    J Hypertens; 2008 Feb; 26(2):303-11. PubMed ID: 18192845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of saralasin in the recognition of angiotensinogenic hypertension.
    Streeten DH; Dalakos TG; Anderson GH
    Prog Biochem Pharmacol; 1976; 12():214-26. PubMed ID: 1019165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Renin-angiotensin-aldosterone system in the treatment of essential hypertension with a beta-adrenergic blocker: sotalol].
    Psadas C; Sánchez G; Zaldívar HM; Rangel J; Cuéllar A; Serrano PA
    Arch Inst Cardiol Mex; 1977; 47(2):160-70. PubMed ID: 901052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Renin-angiotensin-aldosterone system in essential hypertension. Inappropriately high plasma aldosterone in young patients with severe hypertension and in older hypertensives].
    Vetter H; Zumkley H; Glänzer K; Witassek F; Wollnik S; Vetter W
    Schweiz Med Wochenschr; 1980 Dec; 110(50):1938-41. PubMed ID: 7010579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.